Registration Header

Women’s Health Through Probiotics –
join us as we explore the science behind the strains


Facebook LinkedIn Twitter  

Start Date: 4th March 2021

Start Time: 8:00 AM CST / 3:00 PM CET

Duration:60 minutes


As science and consumer interest in probiotics take us beyond the gut, women’s health takes center stage. Today, women’s health is viewed as one of the fastest-growing categories in the probiotics space, and for good reason! Join Chr. Hansen as we discuss the clinical documentation supporting our women’s health probiotic strains. From urogenital health to pregnancy and healthy ageing, our portfolio offers you the ability to target the specific health benefits your customer wants, with the science they deserve


Daniel Hovel Hansen

Head of Infant & Women’s Health
Chr. Hansen

Building on a significant career in commercial roles within the consumer goods industry, Daniel has a strong understanding of consumers and their preferences. Since joining the company in 2019 he has been responsible for developing Chr. Hansen’s new Women’s Health strategy and the strongly enhanced range of Women’s Health solutions. Daniel is passionate about taking probiotics in Women’s Health to new levels, proving that probiotics are relevant across all life stages and a broad variety of areas within Women’s Health.

Christina Birkedal

Director of Global Product Portfolio, Human Health
Chr. Hansen

Christina is passionate about driving strategic direction of the Human Health global product portfolio in close collaboration across Scientific Affairs and Sales. Christina has strong commercial experience from 15+ years with world leading companies in the consumer goods industry.

Ulla Gondolf

Head of Scientific Advisors in Human Health
Chr. Hansen

Ulla is Head of the Scientific Advisors in Human Health. She has a PhD in human nutrition and has 8 years of experience as Scientific Advisor within the dietary supplement industry. She works with clinical study results, focusing on the mechanisms and effects of probiotic strains within gastrointestinal, immune and urogenital health.

Jane Thompson

Scientific Advisor
Chr. Hansen

Jane has a PhD in biomedical sciences, in which she investigated molecular and physiological markers of cardiovascular risk. She has three years of post-doctoral research experience. Jane has worked in the probiotics field since 2019 and is a Scientific Advisor within Human Health at Chr. Hansen.

First Name


Last Name
Job Title
Work Phone
Email Address
Got a burning question about this topic? Send it to us using the box below and we will try to have it answered by our expert panellists. You are also welcome to ask questions on the live day.

This Webinar is a free service provided to you by William Reed Business Media Ltd and this service is produced by Chr. Hansen. In order for you to receive this content, the above data is provided to Chr. Hansen, the content producer.

William Reed Business Media Ltd. may use your contact data to keep you informed of its products and services by email or by phone. You can withdraw your marketing consent at any time by clicking the unsubscribe link in such email or by sending an email to

More information on our processing can be found in our Privacy Notice. By submitting this form, you acknowledge that you have read and understand our Privacy Notice